Optimization of intervention components in Atopic dermatitis management applications: A focus group interview study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007675

Enrollment

Registered

2022-09-02

Start date

2022-08-17

Completion date

Unknown

Last updated

2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Digital Intervention for Clinical Trials) : The test groups are provided with digital intervention for clinical trials based on cognitive behavioral therapy in the form of an app. *Even if th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient who meets all the selection criteria - Atopic dermatitis patients over the age of 13 - Patients who have no difficulty reading and writing Korean - Patients who have no difficulty using a mobile application using a smartphone - Patients who voluntarily decide to participate and agree in writing to comply with precautions after hearing and understanding sufficient explanation of this clinical trial - Patients who voluntarily agree and can visit for observation

Exclusion criteria

Exclusion criteria: Anyone who falls under any of the exclusion criteria - Those who have difficulty in using surveys and applications without the help of doctor or protector - Those who have not been confirmed to have atopic dermatitis - Those who go against their will - Subjects in critical or vulnerable environments - Those who have difficulty hearing, writing, and speaking Korean - Those who have difficulty using general-purpose equipment - Those who are judged to be non-compliant to participate in this clinical trial - Those who do not understand the purpose and method of this clinical trial, or who are judged to be difficult to conduct this clinical trial by a researcher - Those who are judged to be inappropriate to participate in the clinical trial by the researcher for other reasons

Design outcomes

Primary

Measure	Time frame
Subjective feasibility	—

Secondary

Measure	Time frame
Eczema Area and Severity Index (EASI);Patient-Oriented Eczema Measure(POEM);Quality of life and fear scales (DLQI and BFNE);Insomnia Severity Index (ISI);Perceived Stress Scale (PSS);Bath and moisturizer use scores	—

Countries

Korea, Republic of

Contacts

Public ContactHye Rim Lee

Yonsei University

lhr1630@yonsei.ac.kr+82-2-2228-1881

Outcome results